Literature DB >> 7049921

Blood pressure and hormone changes associated with weight reduction in the obese.

J R Sowers, M Nyby, N Stern, F Beck, S Baron, R Catania, N Vlachis.   

Abstract

This study examines factors modulating blood pressure reduction in obese patients undergoing weight reduction on a low calorie protein diet. Plasma norepinephrine (NE) was correlated (r = 0.65, p less than 0.01) with blood pressure in 20 obese patients prior to weight loss. Reductions in blood pressure levels following upright posture and isometric handgrip exercise were related to reduction in NE levels after these maneuvers. While plasma epinephrine levels declined in parallel with NE levels, plasma dopamine actually increased (p less than 0.05) during the first 2 weeks of caloric restriction. Prior to weight loss the obese patients demonstrated a significant rise in prolactin levels following posture and exercise, but following caloric restriction this was not observed. Levels of plasma renin activity (PRA) and aldosterone obtained after posture and exercise maneuvers were reduced after 8 weeks of caloric restriction, and reductions in PRA were related to reductions in NE (r = 0.56, p less than 0.01). Reductions in blood pressure in association with caloric restriction in these obese patients seems to result, in part, from reduced sympathetic nervous system activity as well as secondary effects of reduced adrenergic activity on renal sodium excretion and the renin-angiotensin-aldosterone axis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049921     DOI: 10.1161/01.hyp.4.5.686

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  24 in total

Review 1.  Nonesterified fatty acids in blood pressure control and cardiovascular complications.

Authors:  B M Egan; E L Greene; T L Goodfriend
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Malnutrition and the heart.

Authors:  J G Webb; M C Kiess; C C Chan-Yan
Journal:  CMAJ       Date:  1986-10-01       Impact factor: 8.262

Review 3.  Insulin resistance and hypertension--implications for treatment.

Authors:  P A Rutherford; T H Thomas; R Wilkinson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

4.  Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms.

Authors:  M L Tuck; M S Golub; P Eggena; J R Sowers; M Maxwell
Journal:  West J Med       Date:  1983-08

5.  Neuroendocrine alterations in obese patients with sleep apnea syndrome.

Authors:  Fabio Lanfranco; Giovanna Motta; Marco Alessandro Minetto; Matteo Baldi; Marcella Balbo; Ezio Ghigo; Emanuela Arvat; Mauro Maccario
Journal:  Int J Endocrinol       Date:  2010-02-23       Impact factor: 3.257

Review 6.  Stress and salt sensitivity in primary hypertension.

Authors:  Deborah L Stewart; Gregory A Harshfield; Haidong Zhu; Coral D Hanevold
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 7.  Pathophysiology of sympathoadrenal system.

Authors:  R Giorgino
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

Review 8.  Insulin resistance and the sympathetic nervous system.

Authors:  Brent M Egan
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

9.  Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction.

Authors:  B Fagerberg; O K Andersson; B Isaksson; P Björntorp
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-07

Review 10.  Role of ambulatory blood pressure monitoring in hypertension and diabetes.

Authors:  Colleen Flynn; George L Bakris
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.